Verified peer comparison
Q32 Bio vs Agios Pharmaceuticals Financial Comparison
Direct answer
Q32 Bio and Agios Pharmaceuticals are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Q32 Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Q32 Bio Revenue
- 53,737,000 USD
- Agios Pharmaceuticals Revenue
- 54,028,000 USD
- Q32 Bio Operating income
- 16,902,000 USD
- Agios Pharmaceuticals Operating income
- -472,132,000 USD